Teva: brands it owns and its ownership tree
Teva (NYSE: TEVA) is a publicly listed company headquartered in Tel Aviv, Israel that owns 4 consumer brands.[1]
Teva is an Israeli-domiciled pharmaceutical company that sells generic medicines worldwide alongside a growing list of branded innovative drugs. Its 2025 annual report puts the weight of its strategy on four products: AUSTEDO for movement disorders, AJOVY for migraine, UZEDY for schizophrenia and bipolar disorder, and COPAXONE for multiple sclerosis. Its United States operations are run from Parsippany, New Jersey.
-
brands owned
-
1
categories
-
0
acquisitions recorded
-
0
divestitures recorded
Company facts
- Legal name
- Teva Pharmaceutical Industries Limited
- Type
- publicly listed company · see all publicly listed company owners
- Headquarters
- 🇮🇱 Tel Aviv, Israel
- Tickers
- NYSE: TEVA
- SEC CIK
- 0000818686
- Website
- www.tevapharm.com
- Last verified
- · 1 sources
Teva in numbers
- Teva owns 4 consumer brands tracked here across 1 top-level categories; the largest is healthcare & pharma with 4 brands.[1]
Teva financial history
Headline figures from Teva's annual reports filed with the US Securities and Exchange Commission, in USD as reported, fiscal years ending 2020–2025. Revenue moved from $16.7bn to $17.3bn, an average of 0.7% a year (calculated).
| Fiscal year ended | Revenue | Operating income | Operating margin | Net income | Total assets | Long-term debt | Filing |
|---|---|---|---|---|---|---|---|
| $17.3bn | $2.16bn | 12.5% | $1.41bn | $40.7bn | — | 10-K | |
| $16.5bn | $-303,000,000 | -1.8% | $-1,639,000,000 | $39.3bn | — | 10-K | |
| $15.8bn | $433m | 2.7% | $-559,000,000 | $43.5bn | — | 10-K | |
| $14.9bn | $-2,197,000,000 | -14.7% | $-2,446,000,000 | $44bn | — | 10-K | |
| $15.9bn | $1.72bn | 10.8% | $417m | $47.7bn | — | 10-K | |
| $16.7bn | $-3,572,000,000 | -21.4% | $-3,990,000,000 | $50.6bn | — | 10-K |
Source: SEC XBRL company facts. A dash means the company did not report that line in a form we could read. Figures for a year can be restated in a later filing; the latest filing's number is shown.
Everything Teva owns
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Full-screen interactive tree →
Brand portfolio by category
Recent changes to this record
Teva SEC filings
The documents behind the figures on this page, as listed in the SEC's EDGAR index. Each links to the filing itself.
Annual reports
- Annual report, filed (10-K)
- Annual report, filed (10-K)
- Annual report, filed (10-K)
- Annual report, filed (10-K)
- Annual report, filed (10-K)
- Annual report, filed (10-K)
Proxy statements
- Proxy statement, filed (DEF 14A)
- Proxy statement, filed (DEF 14A)
- Proxy statement, filed (DEF 14A)
Recent current and quarterly reports
| Filed | Form | What it declares |
|---|---|---|
| 8-K | Entry into a material agreement; Creation of a direct financial obligation | |
| 8-K | Other events | |
| 8-K | Regulation FD disclosure; Other events | |
| 8-K | Other events | |
| 8-K | Material change to rights of security holders | |
| 10-Q | Quarterly report | |
| 8-K | Results of operations and financial condition | |
| 8-K | Results of a shareholder vote | |
| 10-Q | Quarterly report | |
| 8-K | Results of operations and financial condition; Regulation FD disclosure | |
| 8-K | Results of operations and financial condition | |
| 8-K | Results of operations and financial condition | |
| 8-K | Entry into a material agreement; Creation of a direct financial obligation | |
| 10-Q | Quarterly report |
Frequently asked questions
What brands does Teva own?
Teva owns 4 consumer brands tracked here, including Austedo, Ajovy, Uzedy and Copaxone.
Is Teva an Israeli company?
Yes. Teva is headquartered in Tel Aviv, Israel.
Who owns Teva?
Teva is a publicly listed company owned by its shareholders; it trades as TEVA on the NYSE.
Sources (1) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Teva Pharmaceutical Industries Limited Annual Report on Form 10-K filed 2026-02-03 — SEC EDGAR, SEC Form 10-K, published 3 February 2026; retrieved 10 October 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.